Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.
Ticker SymbolCBUS
Company nameCibus Inc
IPO dateJul 20, 2017
CEOBeetham (Peter Ronald)
Number of employees157
Security typeOrdinary Share
Fiscal year-endJul 20
Address6455 Nancy Ridge Drive
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18584500008
Websitehttps://www.cibus.com/
Ticker SymbolCBUS
IPO dateJul 20, 2017
CEOBeetham (Peter Ronald)
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data